BIS ETF Report: Ratings, Analysis, Quotes, Holdings

Popular BIS Comparisons: BIS vs LABD, BIS vs FDG, BIS vs IVRA, BIS vs ACES, BIS vs ACIO

Find more ETFs with our ETF Screener and Database

*Unless otherwise stated, data provided by FactSet.

BIS Fund Description

BIS provides -2x exposure to a market-cap weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

BIS Factset Analytics Insight

BIS provides daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index. It charges 95 bps for holding swaps on the index and the iShares Biotech ETF (IBB), which reaches beyond pure biotechnology into pharmaceuticals, and tilts smaller than our benchmark, in addition to excluding NYSE-listed firms. BIS has increased assets to a reasonable level, which has helped liquidity for investors, though spreads are still sizeable. Unfortunately, BIS is the only fund in the inverse biotech space. Note: BIS is a tactical tool. Due to daily compounding, it's unlikely to achieve its stated exposure and returns for longer than a one-day period, but with its high expense ratio, most investors probably won't want to hang onto it for long anyway.

BIS Charts And Performance

1 Month
3 Months
YTD
1 Year
3 Years
5 Years
Max

Compare

Reset

Select ETFs to compare their performance:

PERFORMANCE [as of 01/20/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS

BIS -12.06% -34.87% -16.50% -62.49% -36.84% -33.67% -41.04%

BIS (NAV) -11.63% -33.66% -16.10% -62.24% -36.72% -34.30% -41.01%

NASDAQ Biotechnology Index 6.17% 21.21% 9.07% 36.43% 14.41% 12.27% 18.55%

N/A -- -- -- -- -- -- --

All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

BIS Summary Data

ProShares

04/08/10

Open-Ended Fund

0.95%

$8.78M

0.06%

LABD

Fund Home Page

BIS Portfolio Data

0.53%

N/A

BIS Index Data

NASDAQ Biotechnology Index

Market Cap

NASDAQ - Listed

N/A

BIS Fund Structure

Yes

No Policy

N/A

High

-2

Leverage Reset Frequency Daily

BIS Tax Exposures

20.00% / 39.60%

Cboe Book Viewer

Top Of Book

Last 10 Trades

Bats BZX Real-time Quote -

BIS Factset Analytics Block Liquidity

As of 01/22/21

This measurement shows how easy it is to trade a $1 million USD block of BIS. BIS is rated a N/A out of 5.

BIS Tradability

51,528

$1.23M

49,828

$1.12M

0.06%

$0.02

0.00%

300.44% / -0.58%

None

100.00%

50,000

1.00

0.02%

385

$19.77

N/A

The data and information contained herein is not intended to be investment or tax advice. A reference to a particular investment or security, a credit rating, or any observation concerning a security or investment provided in the ETF.com Service is not a recommendation to buy, sell, or hold such investment or security or to make any other investment decisions. You should not use such information for purposes of any actual transaction without consulting an investment or tax professional.

ETF.com DOES NOT TAKE RESPONSIBILITY FOR YOUR INVESTMENT OR OTHER ACTIONS NOR SHALL ETF.com HAVE ANY LIABILITY, CONTINGENT OR OTHERWISE, FOR THE ACCURACY, COMPLETENESS, TIMELINESS, OR CORRECT SEQUENCING OF ANY INFORMATION PROVIDED BY ETF.com OR FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE UPON SUCH INFORMATION OR ETF.com.

[ETF.com DOES NOT PROVIDE ANY RESEARCH OPINIONS.] ETF.com MAKES NO REPRESENTATIONS ABOUT THE SUITABILITY OF THE INFORMATION, PRODUCTS OR SERVICES CONTAINED HEREIN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.

Data provider:
Terms of Use

BIS